These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 21166753)

  • 21. Risk factors and outcomes of urethral recurrence following radical cystectomy.
    Boorjian SA; Kim SP; Weight CJ; Cheville JC; Thapa P; Frank I
    Eur Urol; 2011 Dec; 60(6):1266-72. PubMed ID: 21871713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.
    Kassouf W; Swanson D; Kamat AM; Leibovici D; Siefker-Radtke A; Munsell MF; Grossman HB; Dinney CP
    J Urol; 2006 Jun; 175(6):2058-62. PubMed ID: 16697803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy.
    Sonpavde G; Khan MM; Svatek RS; Lee R; Novara G; Tilki D; Lerner SP; Amiel GE; Skinner E; Karakiewicz PI; Bastian PJ; Kassouf W; Fritsche HM; Izawa JI; Ficarra V; Dinney CP; Lotan Y; Fradet Y; Shariat SF
    BJU Int; 2011 Sep; 108(5):687-92. PubMed ID: 21087453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy.
    Linder BJ; Frank I; Cheville JC; Tollefson MK; Thompson RH; Tarrell RF; Thapa P; Boorjian SA
    Eur Urol; 2013 May; 63(5):839-45. PubMed ID: 23332883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors.
    Kassouf W; Spiess PE; Brown GA; Munsell MF; Grossman HB; Siefker-Radtke A; Dinney CP; Kamat AM
    Eur Urol; 2007 Sep; 52(3):769-74. PubMed ID: 17434254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical factors influence bladder cancer outcomes: a cooperative group report.
    Herr HW; Faulkner JR; Grossman HB; Natale RB; deVere White R; Sarosdy MF; Crawford ED
    J Clin Oncol; 2004 Jul; 22(14):2781-9. PubMed ID: 15199091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience.
    Efstathiou JA; Spiegel DY; Shipley WU; Heney NM; Kaufman DS; Niemierko A; Coen JJ; Skowronski RY; Paly JJ; McGovern FJ; Zietman AL
    Eur Urol; 2012 Apr; 61(4):705-11. PubMed ID: 22101114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perivesical fat invasion in bladder cancer: implications for prognosis comparing pT2b, pT3a and pT3b stages and consequences for adjuvant chemotherapy indications.
    Neuzillet Y; Lebret T; Molinie V; Yonneau L; Herve JM; Theodore C; Botto H
    BJU Int; 2012 Dec; 110(11):1736-41. PubMed ID: 22998125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy.
    Chromecki TF; Cha EK; Fajkovic H; Rink M; Ehdaie B; Svatek RS; Karakiewicz PI; Lotan Y; Tilki D; Bastian PJ; Daneshmand S; Kassouf W; Durand M; Novara G; Fritsche HM; Burger M; Izawa JI; Brisuda A; Babjuk M; Pummer K; Shariat SF
    BJU Int; 2013 Feb; 111(2):249-55. PubMed ID: 22727036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presentation, location and overall survival of pelvic recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
    Dhar NB; Jones JS; Reuther AM; Dreicer R; Campbell SC; Sanii K; Klein EA
    BJU Int; 2008 Apr; 101(8):969-72. PubMed ID: 18005201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does partial cystectomy compromise oncologic outcomes for patients with bladder cancer compared to radical cystectomy? A matched case-control analysis.
    Knoedler JJ; Boorjian SA; Kim SP; Weight CJ; Thapa P; Tarrell RF; Cheville JC; Frank I
    J Urol; 2012 Oct; 188(4):1115-9. PubMed ID: 22901583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy.
    Kassouf W; Leibovici D; Munsell MF; Dinney CP; Grossman HB; Kamat AM
    J Urol; 2006 Jul; 176(1):53-7; discussion 57. PubMed ID: 16753366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
    J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radical cystectomy for urothelial carcinoma of the bladder: an analysis of perioperative and survival outcome.
    Manoharan M; Ayyathurai R; Soloway MS
    BJU Int; 2009 Nov; 104(9):1227-32. PubMed ID: 19519764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors and outcome in patients with T1 high-grade bladder cancer: can we identify patients for early cystectomy?
    Segal R; Yafi FA; Brimo F; Tanguay S; Aprikian A; Kassouf W
    BJU Int; 2012 Apr; 109(7):1026-30. PubMed ID: 21883838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intermediate-term oncologic outcomes of robot-assisted radical cystectomy for urothelial carcinoma.
    Yuh B; Torrey RR; Ruel NH; Wittig K; Tobis S; Linehan J; Lau CS; Chan KG; Yamzon J; Wilson TG
    J Endourol; 2014 Aug; 28(8):939-45. PubMed ID: 24635448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study.
    Koga F; Kihara K; Fujii Y; Yoshida S; Saito K; Masuda H; Kageyama Y; Kawakami S
    BJU Int; 2009 Jul; 104(2):189-94. PubMed ID: 19154452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations between comorbidity, and overall survival and bladder cancer specific survival after radical cystectomy: results from the Alberta Urology Institute Radical Cystectomy database.
    Fairey AS; Jacobsen NE; Chetner MP; Mador DR; Metcalfe JB; Moore RB; Rourke KF; Todd GT; Venner PM; Voaklander DC; Estey EP
    J Urol; 2009 Jul; 182(1):85-92; discussion 93. PubMed ID: 19447413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early oncological outcomes for bladder urothelial carcinoma patients treated with robotic-assisted radical cystectomy.
    Kauffman EC; Ng CK; Lee MM; Otto BJ; Wang GJ; Scherr DS
    BJU Int; 2011 Feb; 107(4):628-35. PubMed ID: 20883479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.